Gide has advised Investindustrial portfolio company Farmaceutici Procemsa on its acquisition of a majority stake in Poland's Master Pharm.
The transaction remains contingent on regulatory approval.
Founded in Turin in 1939, Procemsa specializes in contract development, manufacturing, and packaging of vitamins, food supplements, proprietary formulations, and cosmetics-pharmaceuticals for third parties.
Master Pharm is a contract development and manufacturing company in Poland. Founded in 2002 and headquartered in Lodz, Master Pharm manufactures dietary supplements.
According to Gide, “this acquisition is an important milestone for Procemsa as part of its consolidation strategy of the European Contract Development and Manufacturing Organisation market and reinforces its European presence by enhancing its geographic and customer diversification in the fast-growing Eastern European market.”
The Gide team included Partner Pawel Grzeskowiak, Senior Associate Wojciech Czyzewski, and Associate Magdalena Zawislak.
Gide did not respond to our inquiry on the matter.
